ANTX

An 2 Therapeutics Stock Analysis

AI Rating

Neutral
  • Quality2/10
  • Growth↑ 7/10
  • Value↓ 1/10
An 2 Therapeutics sales and earnings growth
ANTX Growth
Good
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 32.56%
  • FCF Y/Y↑ 39.43%
An 2 Therapeutics gross and profit margin trends
ANTX Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ 2.02%
An 2 Therapeutics net debt vs free cash flow
ANTX Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

An 2 Therapeutics stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

More Biotechnology stocks ↗